Give me that med
This medication is given every 3–5 minutes during cardiac arrest
epinephrine
This is a shockable rhythm with no pulse and chaotic waveform
Ventricular Fibrillation
This is the initial biphasic shock dose for VF/pVT
200 j
One ‘H’ that can be corrected with fluids
Hypovolemia
Patient becomes bradycardic (HR 30) with hypotension under spinal anesthesia. First-line drug?
Atropine
This antiarrhythmic is first-line for shock-refractory VF/pVT
amiodarone
This rhythm has organized electrical activity but no pulse
Pulseless Electrical Activity (PEA)
This action should immediately follow every shock
Resume CPR
One ‘T’ caused by a clot in the lungs
Thrombus- pulmonary
Stable SVT in PACU. First intervention
Vagal
This medication treats stable narrow-complex SVT and must be pushed rapidly
Adenosine
This bradycardic rhythm may require atropine if symptomatic
Sinus Bradycardia
This rhythm requires synchronized cardioversion, not defibrillation
Supraventricular Tachycardia- SVT
This ‘H’ relates to potassium imbalance
Hyper/hypo kalemia
VF persists after 2 shocks. Next medication
Epinephrine
This medication is used for torsades de pointe
Magnesium
This polymorphic VT is associated with prolonged QT
Torsades De Pointe
When doing a synchronized cardioversion what is the first step
SYNC
This ‘T’ may require needle decompression
Tamponade
You've extubated your patient and they are breathing inadequately. The heart rate is dropping. What is your first intervention?
BVM
This medication is NOT routinely recommended in cardiac arrest but may be used in TCA overdose or hyperkalemia
Sodium Bicarbonate
This rhythm is “irregularly irregular,” has no distinct P waves, and carries a risk of clot formation due to ineffective atrial contraction
Bonus- 2 question we must ask before cardioverting
Atrial Fibrillation
This is when you would escalate energy levels during repeated shocks
Persistent VFIB or Pulseless VTACH
This reversible cause may require antidotes like naloxone
Toxin
ETCO2 is <10 during CPR. What do you do?
Improve CPR